Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC).  [electronic resource] 

 -  Annals of the Academy of Medicine, Singapore  Oct 2015 
 - 406-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline 
<br/><br/><label>ISSN: </label>2972-4066 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Axitinib<br/>Bevacizumab--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Everolimus--therapeutic use<br/>Humans<br/>Imidazoles--therapeutic use<br/>Indazoles--therapeutic use<br/>Indoles--therapeutic use<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--therapeutic use<br/>Kidney Neoplasms--pathology<br/>Nephrectomy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Pyrroles--therapeutic use<br/>Singapore<br/>Sirolimus--analogs & derivatives<br/>Sorafenib<br/>Sulfonamides--therapeutic use<br/>Sunitinib